Features
Richard Jushchyshyn, Rich Holzchuh and Xavier Chaveton
September 21, 2005
New coding and marking technologies can help combat counterfeiting, comply with FDA regs and increase profits
Read More »
September 21, 2005
The Top 10 Biopharma rankings saw two more companies reach the billion-dollar mark in revenues in 2004, as Gilead and MedImmune crossed that threshold. Unfortunately, a bad case of the flu sent Chiron back under the billion-dollar mark, as its fluvirin vaccine revenues dropped from $219 million in 2003 to a mere $2 million last year, after its well-documented manufacturing problems.
Read More »
September 21, 2005
Our editorial staff has gathered information from annual reports, interviews, and analyst coverage to compile a list of the previous year's Top 20 players in the Pharma arena.
Read More »
Gil Y. Roth
August 23, 2005
2005 Salary Survey
Please click here to download the Salary Survey as a PDF…
Read More »
Faiz Kermani and Camille Lovell-Hoare
August 23, 2005
With great power comes great responsibilities
Read More »
